We are live on ! Find out more
FLNA

Filana Therapeutics

46 hedge funds and large institutions have $10.9M invested in Filana Therapeutics in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.93% more ownership

Funds ownership: 0%5.93% (+5.9%)

4% less funds holding

Funds holding: 4846 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

25% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 16

48% less capital invested

Capital invested by funds: $20.9M → $10.9M (-$9.94M)

Holders
46
Holders Change
-2
Holders Change %
-4.17%
% of All Funds
1.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
12
Reduced
16
Closed
8
Calls
$4K
Puts
Net Calls
+$4K
Net Calls Change
-$176K
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
51
Creative Planning
Kansas
+$223 +48 New

FLNA Hedge Fund Activity: Q4 2016 in Review

46 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2016, worth a combined $10.9M — down 48% from $20.9M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of FLNA and 6 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 12 added.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $305K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $628K sold.

  • 46 institutional investors held Filana Therapeutics (FLNA) as of Q4 2016, down from 48 in Q3 2016.
  • Funds reported $10.9M of Filana Therapeutics stock for Q4 2016, down 48% quarter-over-quarter.
  • 6 funds opened new Filana Therapeutics positions in Q4 2016 and 8 closed out, a net change of -2 holders.
  • The largest Filana Therapeutics buyer in Q4 2016 was Anson Funds Management, an estimated $305K added.
  • The largest Filana Therapeutics seller in Q4 2016 was Dimensional Fund Advisors, an estimated $628K sold.

Based on aggregated 13F filings for Q4 2016.